ClearPoint Neuro, Inc.
CLPT
$12.97
-$0.14-1.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.33M | 33.59M | 32.24M | 31.39M | 30.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.33M | 33.59M | 32.24M | 31.39M | 30.43M |
| Cost of Revenue | 13.28M | 13.30M | 12.51M | 12.27M | 12.06M |
| Gross Profit | 21.05M | 20.30M | 19.73M | 19.12M | 18.37M |
| SG&A Expenses | 29.78M | 29.05M | 28.23M | 26.43M | 25.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.06M | 56.20M | 53.89M | 51.09M | 49.23M |
| Operating Income | -22.72M | -22.61M | -21.65M | -19.70M | -18.80M |
| Income Before Tax | -23.09M | -22.17M | -20.75M | -18.87M | -18.10M |
| Income Tax Expenses | 51.00K | 57.00K | 47.00K | 44.00K | 44.00K |
| Earnings from Continuing Operations | -23.14 | -22.22 | -20.79 | -18.91 | -18.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.14M | -22.22M | -20.79M | -18.91M | -18.15M |
| EBIT | -22.72M | -22.61M | -21.65M | -19.70M | -18.80M |
| EBITDA | -21.92M | -21.60M | -20.81M | -18.72M | -17.88M |
| EPS Basic | -0.83 | -0.80 | -0.75 | -0.70 | -0.69 |
| Normalized Basic EPS | -0.52 | -0.50 | -0.47 | -0.44 | -0.43 |
| EPS Diluted | -0.83 | -0.80 | -0.75 | -0.70 | -0.69 |
| Normalized Diluted EPS | -0.52 | -0.50 | -0.47 | -0.44 | -0.43 |
| Average Basic Shares Outstanding | 112.00M | 111.16M | 110.37M | 108.10M | 105.14M |
| Average Diluted Shares Outstanding | 112.00M | 111.16M | 110.37M | 108.10M | 105.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |